Probenecid
DrugBank ID: DB01032
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 1 |
| DL Only | 49 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| obsolete hyperuricemia (disease) | 0.9984 | KG+DL |
| hypouricemia, renal | 0.9973 | DL |
| Lesch-Nyhan syndrome | 0.9939 | DL |
| hypoxanthine guanine phosphoribosyltransferase partial deficiency | 0.9937 | DL |
| cholelithiasis | 0.9774 | DL |
| early-onset familial noncirrhotic portal hypertension | 0.9659 | DL |
| hepatoportal sclerosis | 0.9659 | DL |
| hepatopulmonary syndrome | 0.9659 | DL |
| idiopathic copper-associated cirrhosis | 0.9659 | DL |
| primitive portal vein thrombosis | 0.9659 | DL |
| disorder of phenylalanine metabolism | 0.9658 | DL |
| hepatic porphyria | 0.9643 | DL |
| genetic otorhinolaryngological malformation | 0.9619 | DL |
| neonatal epileptic encephalopathy due to glutaminase deficiency | 0.9592 | DL |
| idiopathic bilateral vestibulopathy | 0.9569 | DL |
| semicircular canal dehiscence syndrome | 0.9569 | DL |
| juvenile nasopharyngeal angiofibroma (disease) | 0.9556 | DL |
| familial nasal acilia | 0.9552 | DL |
| gout | 0.9547 | DL |
| silent sinus syndrome | 0.9534 | DL |
| inborn disorder of phenylalanin or tyrosine metabolism | 0.9513 | DL |
| tetrahydrobiopterin metabolic process disease | 0.9488 | DL |
| maternal hyperthermia induced birth defects | 0.9481 | DL |
| disorder of tyrosine metabolism | 0.9465 | DL |
| cleft lip/palate-intestinal malrotation-cardiopathy syndrome | 0.9458 | DL |
| craniorhiny | 0.9454 | DL |
| fetal minoxidil syndrome | 0.9452 | DL |
| phenobarbital embryopathy | 0.9445 | DL |
| brain small vessel disease 1 with or without ocular anomalies | 0.9442 | DL |
| fetal trimethadione syndrome | 0.9442 | DL |
| Bencze syndrome | 0.9436 | DL |
| branchial cleft anomaly | 0.9420 | DL |
| velo-facial-skeletal syndrome | 0.9418 | DL |
| mandibulofacial dysostosis-macroblepharon-macrostomia syndrome | 0.9415 | DL |
| phenylketonuria | 0.9400 | DL |
| diabetic embryopathy | 0.9400 | DL |
| autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | 0.9392 | DL |
| teratogenic Pierre Robin syndrome | 0.9392 | DL |
| hereditary renal hypouricemia | 0.9292 | DL |
| propylthiouracil embryofetopathy | 0.9288 | DL |
| indomethacin embryofetopathy | 0.9272 | DL |
| glycogen storage disease due to hepatic glycogen synthase deficiency | 0.9222 | DL |
| tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | 0.9215 | DL |
| cocaine embryofetopathy | 0.9201 | DL |
| tibial aplasia-ectrodactyly syndrome | 0.9147 | DL |
| aminopterin/methotrexate embryofetopathy | 0.9111 | DL |
| toluene embryopathy | 0.9104 | DL |
| selective IgG subclass deficiency | 0.8900 | DL |
| obsolete familial combined hyperlipidemia | 0.8890 | DL |
| diabetic nephropathy | 0.8833 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.